Company Profiles

driven by the PitchBook Platform

TheraVasc

Description

Developer of therapies and treatments for chronic medical diseases. The company's first product is TV1001, an oral formulation of sodium nitrite to treat PAD (Peripheral Artery Disease) and to determine safety and blood levels of the drug, targeting patient populations with poor blood flow to the extremities, such as those with diabetic leg and foot problems or those with peripheral artery disease.

2009

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$4.24M

Total Amount Raised

11

Investors

Description

Developer of therapies and treatments for chronic medical diseases. The company's first product is TV1001, an oral formulation of sodium nitrite to treat PAD (Peripheral Artery Disease) and to determine safety and blood levels of the drug, targeting patient populations with poor blood flow to the extremities, such as those with diabetic leg and foot problems or those with peripheral artery disease.

Website:

www.theravasc.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

10000 Cedar Avenue MS Suite 1 Cleveland, OH 44106United States +1 (318) 349-3851
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore TheraVasc's full profile, request a free trial.

TheraVasc Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

TheraVasc Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

TheraVasc Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Global Cardiovascular Innovation CenterAccelerator/IncubatorMinority000 0000000 0000
Great Lakes Innovation and Development EnterpriseAccelerator/IncubatorMinority000 0000000 0000
Innovation Fund of Northeast OhioAccelerator/IncubatorMinority000 0000000 0000
JumpStartAccelerator/IncubatorMinority000 0000000 0000
North Coast Angel FundAngel GroupMinority000 0000000 0000
Global Cardiovascular Innovation Center Accelerator/Incubator
Great Lakes Innovation and Development Enterprise Accelerator/Incubator
Innovation Fund of Northeast Ohio Accelerator/Incubator
JumpStart Accelerator/Incubator
North Coast Angel Fund Angel Group

TheraVasc Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Chris Kevil Ph.DCo-Founder, Chief Scientific Advisor & Chief Scientific Officer
Douglas Flanagan Ph.DFormulation Supervisor
Anthony Giordano Ph.DCo-Founder, Chief Executive Officer, Board Member and President
Chris Kevil Ph.D Co-Founder, Chief Scientific Advisor & Chief Scientific Officer
Douglas Flanagan Ph.D Formulation Supervisor
Anthony Giordano Ph.D Co-Founder, Chief Executive Officer, Board Member and President

TheraVasc Board Members (6)

NameRepresentingRoleSinceContact
Info
Amol SoinTheraVascChief Medical Officer, Chief Clinical Advisor & Board Member000 0000
Anthony Giordano Ph.DSelfCo-Founder, Chief Executive Officer, Board Member and President000 0000
John HustonOhio Tech AngelsCo-Founder000 0000
Kyle Chan Ph.DSelfBoard Member000 0000
Susan LuriaSelfBoard Member000 0000
Amol Soin Chief Medical Officer, Chief Clinical Advisor & Board Member TheraVasc
Anthony Giordano Ph.D Co-Founder, Chief Executive Officer, Board Member and President Self
John Huston Co-Founder Ohio Tech Angels
Kyle Chan Ph.D Board Member Self
Susan Luria Board Member Self
Request full access to PitchBook